Your browser doesn't support javascript.
loading
MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype.
Smol, T; Petit, F; Piton, A; Keren, B; Sanlaville, D; Afenjar, A; Baker, S; Bedoukian, E C; Bhoj, E J; Bonneau, D; Boudry-Labis, E; Bouquillon, S; Boute-Benejean, O; Caumes, R; Chatron, N; Colson, C; Coubes, C; Coutton, C; Devillard, F; Dieux-Coeslier, A; Doco-Fenzy, M; Ewans, L J; Faivre, L; Fassi, E; Field, M; Fournier, C; Francannet, C; Genevieve, D; Giurgea, I; Goldenberg, A; Green, A K; Guerrot, A M; Heron, D; Isidor, B; Keena, B A; Krock, B L; Kuentz, P; Lapi, E; Le Meur, N; Lesca, G; Li, D; Marey, I; Mignot, C; Nava, C; Nesbitt, A; Nicolas, G; Roche-Lestienne, C; Roscioli, T; Satre, V; Santani, A.
Afiliação
  • Smol T; Institut de Génétique Médicale, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.
  • Petit F; University of Lille, EA 7364-RADEME, Lille, France.
  • Piton A; University of Lille, EA 7364-RADEME, Lille, France.
  • Keren B; Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, avenue Eugène Avinée, Lille, France.
  • Sanlaville D; Laboratoire de diagnostic génétique, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Afenjar A; Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Baker S; Service de Génétique, Hospices Civils de Lyon, Lyon, France.
  • Bedoukian EC; Service de Génétique, Hôpital d'Enfants Armand-Trousseau, AP-HP, Paris, France.
  • Bhoj EJ; Department of Pathology Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Bonneau D; Roberts Individualized Medical Genetics Center, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Boudry-Labis E; Department of Pathology Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Bouquillon S; Service de Génétique, CHU d'Angers, Angers, France.
  • Boute-Benejean O; Institut de Génétique Médicale, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.
  • Caumes R; Institut de Génétique Médicale, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.
  • Chatron N; University of Lille, EA 7364-RADEME, Lille, France.
  • Colson C; Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, avenue Eugène Avinée, Lille, France.
  • Coubes C; Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, avenue Eugène Avinée, Lille, France.
  • Coutton C; Service de Génétique, Hospices Civils de Lyon, Lyon, France.
  • Devillard F; University of Lille, EA 7364-RADEME, Lille, France.
  • Dieux-Coeslier A; Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, avenue Eugène Avinée, Lille, France.
  • Doco-Fenzy M; Département de Génétique Médicale, CHU Montpellier, Montpellier, France.
  • Ewans LJ; Laboratoire de Génétique Chromosomique, CHU Grenoble Alpes, Grenoble, France.
  • Faivre L; Laboratoire de Génétique Chromosomique, CHU Grenoble Alpes, Grenoble, France.
  • Fassi E; University of Lille, EA 7364-RADEME, Lille, France.
  • Field M; Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, avenue Eugène Avinée, Lille, France.
  • Fournier C; Service de Génétique, EA3801, SFR-CAP Santé, CHU de Reims, Reims, France.
  • Francannet C; St Vincent's Clinical School, University of New South Wales, Darlinghurst, New South Wales, Australia.
  • Genevieve D; Centre de Génétique et Centre de Référence Maladies Rares 'Anomalies du Développement, CHU Dijon, Dijon, France.
  • Giurgea I; Equipe GAD, UMR INSERM 1231, Université de Bourgogne, Dijon, France.
  • Goldenberg A; Division of Genetics and Genomic Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
  • Green AK; The Genetics of Learning Disability Service, Waratah, New South Wales, Australia.
  • Guerrot AM; Laboratoire de diagnostic génétique, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Heron D; Service de Génétique Médicale, CHU de Clermont-Ferrand, Clermont-Ferrand, France.
  • Isidor B; Département de Génétique Médicale, CHU Montpellier, Montpellier, France.
  • Keena BA; Service de Génétique, Hôpital Trousseau, AP-HP, Paris, France.
  • Krock BL; Service de Génétique et Inserm U1079, Centre Normand de Génomique Médicale et Médecine Personnalisée, CHU de Rouen, Inserm et Université de Rouen, Rouen, France.
  • Kuentz P; Department of Clinical Genetics, University Hospital Linköping, Linköping, Sweden.
  • Lapi E; Service de Génétique et Inserm U1079, Centre Normand de Génomique Médicale et Médecine Personnalisée, CHU de Rouen, Inserm et Université de Rouen, Rouen, France.
  • Le Meur N; Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Lesca G; Service de Génétique Médicale, Unité de Génétique Clinique, CHU de Nantes, Nantes, France.
  • Li D; Clinical Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Marey I; Department of Pathology Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Mignot C; Equipe GAD, UMR INSERM 1231, Université de Bourgogne, Dijon, France.
  • Nava C; Medical Genetics Unit, Anna Meyer Children's University Hospital, Florence, Italy.
  • Nesbitt A; Service de Génétique et Inserm U1079, Centre Normand de Génomique Médicale et Médecine Personnalisée, CHU de Rouen, Inserm et Université de Rouen, Rouen, France.
  • Nicolas G; Service de Génétique, Hospices Civils de Lyon, Lyon, France.
  • Roche-Lestienne C; Department of Pathology Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Roscioli T; Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Satre V; Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
  • Santani A; Département de Génétique, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Paris, France.
Neurogenetics ; 19(2): 93-103, 2018 05.
Article em En | MEDLINE | ID: mdl-29511999
ABSTRACT
Molecular anomalies in MED13L, leading to haploinsufficiency, have been reported in patients with moderate to severe intellectual disability (ID) and distinct facial features, with or without congenital heart defects. Phenotype of the patients was referred to "MED13L haploinsufficiency syndrome." Missense variants in MED13L were already previously described to cause the MED13L-related syndrome, but only in a limited number of patients. Here we report 36 patients with MED13L molecular anomaly, recruited through an international collaboration between centers of expertise for developmental anomalies. All patients presented with intellectual disability and severe language impairment. Hypotonia, ataxia, and recognizable facial gestalt were frequent findings, but not congenital heart defects. We identified seven de novo missense variations, in addition to protein-truncating variants and intragenic deletions. Missense variants clustered in two mutation hot-spots, i.e., exons 15-17 and 25-31. We found that patients carrying missense mutations had more frequently epilepsy and showed a more severe phenotype. This study ascertains missense variations in MED13L as a cause for MED13L-related intellectual disability and improves the clinical delineation of the condition.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complexo Mediador / Deficiência Intelectual Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complexo Mediador / Deficiência Intelectual Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Child / Child, preschool / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article